Overview

Response of FeNO, Small Airway Dysfunction and Lung Heterogeneity to 2-week Montelukast Treatment in Asthmatic Children.

Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
This study aims to identify markers to prove rapid improvement of lung function, airway inflammation and bronchodilator response after 2-week LTRA administration.
Phase:
N/A
Details
Lead Sponsor:
CHA University
Collaborator:
Merck Sharp & Dohme Corp.
Treatments:
Montelukast